These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 29037248)
1. Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat. Davis KH; Su J; González JM; Trudeau JJ; Nelson LM; Hauber B; Hollis KA Health Qual Life Outcomes; 2017 Oct; 15(1):201. PubMed ID: 29037248 [TBL] [Abstract][Full Text] [Related]
2. A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD. Miravitlles M; Montero-Caballero J; Richard F; Santos S; Garcia-Rivero JL; Ortega F; Ribera X Int J Chron Obstruct Pulmon Dis; 2016; 11():407-15. PubMed ID: 27013871 [TBL] [Abstract][Full Text] [Related]
3. Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma-COPD overlap syndrome consulting for routine care. Ding B; Small M; Scheffel G; Holmgren U Int J Chron Obstruct Pulmon Dis; 2018; 13():927-936. PubMed ID: 29588581 [TBL] [Abstract][Full Text] [Related]
5. Improving usability and maintaining performance: human-factor and aerosol-performance studies evaluating the new reusable Respimat inhaler. Dhand R; Eicher J; Hänsel M; Jost I; Meisenheimer M; Wachtel H Int J Chron Obstruct Pulmon Dis; 2019; 14():509-523. PubMed ID: 30880941 [TBL] [Abstract][Full Text] [Related]
6. COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled study. Ferguson GT; Ghafouri M; Dai L; Dunn LJ Int J Chron Obstruct Pulmon Dis; 2013; 8():139-50. PubMed ID: 23658479 [TBL] [Abstract][Full Text] [Related]
7. Development and validation of a patient satisfaction and preference questionnaire for inhalation devices. Kozma CM; Slaton TL; Monz BU; Hodder R; Reese PR Treat Respir Med; 2005; 4(1):41-52. PubMed ID: 15725049 [TBL] [Abstract][Full Text] [Related]
8. Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners. Molimard M; Colthorpe P J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):219-28. PubMed ID: 25265316 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the preference, satisfaction and correct use of Breezhaler Oliveira MVC; Pizzichini E; da Costa CH; Fritscher CC; Vianna EO; Teixeira PJZ; Stirbulov R; Rabahi MF; Pinho NC Respir Med; 2018 Nov; 144():61-67. PubMed ID: 30366585 [TBL] [Abstract][Full Text] [Related]
10. Factors associated with appropriate inhaler use in patients with COPD - lessons from the REAL survey. Price D; Keininger DL; Viswanad B; Gasser M; Walda S; Gutzwiller FS Int J Chron Obstruct Pulmon Dis; 2018; 13():695-702. PubMed ID: 29520137 [TBL] [Abstract][Full Text] [Related]
11. The Respimat Iwanaga T; Tohda Y; Nakamura S; Suga Y Clin Drug Investig; 2019 Nov; 39(11):1021-1030. PubMed ID: 31377981 [TBL] [Abstract][Full Text] [Related]
12. Inhaler Technique in Asthma: How Does It Relate to Patients' Preferences and Attitudes Toward Their Inhalers? Jahedi L; Downie SR; Saini B; Chan HK; Bosnic-Anticevich S J Aerosol Med Pulm Drug Deliv; 2017 Feb; 30(1):42-52. PubMed ID: 27676193 [TBL] [Abstract][Full Text] [Related]
14. The Respimat Soft Mist Inhaler, a Novel Inhaled Drug Delivery Device. Perriello EA; Sobieraj DM Conn Med; 2016; 80(6):359-64. PubMed ID: 27509644 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI. Zuwallack R; De Salvo MC; Kaelin T; Bateman ED; Park CS; Abrahams R; Fakih F; Sachs P; Pudi K; Zhao Y; Wood CC; Respir Med; 2010 Aug; 104(8):1179-88. PubMed ID: 20172704 [TBL] [Abstract][Full Text] [Related]
16. Inhaler devices in asthma and COPD patients - a prospective cross-sectional study on inhaler preferences and error rates. Schreiber J; Sonnenburg T; Luecke E BMC Pulm Med; 2020 Aug; 20(1):222. PubMed ID: 32819337 [TBL] [Abstract][Full Text] [Related]
17. Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch. Hanada S; Wada S; Ohno T; Sawaguchi H; Muraki M; Tohda Y Int J Chron Obstruct Pulmon Dis; 2015; 10():69-77. PubMed ID: 25609941 [TBL] [Abstract][Full Text] [Related]
18. A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease. Kässner F; Hodder R; Bateman ED Drugs; 2004; 64(15):1671-82. PubMed ID: 15257628 [TBL] [Abstract][Full Text] [Related]
19. Determinants and Differences in Satisfaction with the Inhaler Among Patients with Asthma or COPD. Plaza V; Giner J; Curto E; Alonso-Ortiz MB; Orue MI; Vega JM; Cosío BG; J Allergy Clin Immunol Pract; 2020 Feb; 8(2):645-653. PubMed ID: 31586668 [TBL] [Abstract][Full Text] [Related]
20. Preferences and Inhalation Techniques for Inhaler Devices Used by Patients with Chronic Obstructive Pulmonary Disease. Bournival R; Coutu R; Goettel N; Yang CD; Cantin-Lafleur A; Lemieux C; Lévesque AM; Patenaude-Monette JF; Roy FO; Blais L; Arbour F; Fillion A; Beauchesne MF J Aerosol Med Pulm Drug Deliv; 2018 Aug; 31(4):237-247. PubMed ID: 29206566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]